ATLANTA, Georgia (December 1, 2011) - Implantable Provider Group (IPG), a leading nationwide provider of Implantable Device Benefit Management (DBM) solutions, is pleased to announce they have been named by Forbes magazine as one of "Americas Most Promising Companies." IPG was awarded the 5th place ranking nationwide. IPG capitalized on the tremendous growth in the implantable medical device market, growing its revenues by more than 78% over the past three years, and is currently in contract negotiations with several commercial plans to further accelerate the company's growth as more payors look for solutions to manage the challenges associated with implantable device therapies.

About the Award
Forbes' 2011 list of "America's Most Promising Companies" features 100 privately held up-and-comers with compelling business models, strong management teams, notable customers, strategic partners and precious investment capital. "Sizing up younger, privately held companies is hard: Their fortunes can change very quickly and there's a dearth of public data," says Forbes Executive Editor Brett Nelson. "We took a more comprehensive approach to evaluate their health and potential."

To sharpen its search, Forbes teamed up with CB Insights, a Manhattan-based data firm that tracks investment in high-growth private companies. With $650,000 in grants from the National Science Foundation, CB has developed complex software called Mosaic that mines myriad online sources (from press releases and social networks to job boards and court filings) to come up with one, algorithmically derived score that measures a private company's health. Forbes married Mosaic's data-crunching with old-fashioned reporting to assemble a list of rising stars with bright growth prospects. To view the complete the list, please visit www.forbes.com/ampc.

About Implantable Provider Group (IPG)
Implantable Provider Group (IPG) works with large commercial and workers' compensation payors to develop market-based solutions that deliver tangible value to payors, manufacturers, providers and patients in the Implantable Device Benefit Management (DBM) space. Through its Device Benefit Management (DBM) program, IPG is able to eliminate the complexity and financial risks associated with the billing and reimbursement processes for providers, ensuring that patients maintain access to innovative life-saving and life-enhancing device-intensive medical therapies. For more information about IPG, call us at 1-866-753-0046, or visit us on the web at www.ipgsurgical.com.